Announcement 9567/2022 (no English translation available)
This Announcement is available only in Greek.
Announcement 9564/2022 (no English translation available)
This Announcement is available only in Greek.
ANNOUNCEMENT FOR THE COMPLETION OF FRACTIONAL SHARE SALE
Please see the attached announcement for the completion of fractional shares sale.
ANNOUNCEMENT FOR THE COMPLETION OF FRACTIONAL SHARE SALEANNOUNCEMENT FOR BRIEFING ON Q3'22 TRADING UPDATE
You may find attached the announcement
LAVIPHARM S.A. - ΕΧ RIGHTS ISSUE - PRICE FLUCTUAT. LIMITS OF 28 - 11 - 2022
As of November 28, 2022, the shares of the company "LAVIPHARM S.A." (GRS246003008) are traded on the ATHEX ex-rights in terms of 10.01868413773180 new (CR) shares for every 1 old (CR) share held - with issue of 170,588,235 new CR shares - at an issue price of €0.34 per share. The rights' trading period is set from December 1, 2022, to December 9, 2022 (included). The rights' subscription period is set from December 1, 2022, to December 14, 2022 (included).
Notification of change in the composition of the Board of Directors
Notification of change in the composition of the Board of Directors
Notification of change in the composition of the Board of Directors